dc.contributor.author | Ysselstein, D | en_US |
dc.contributor.author | Dehay, B | en_US |
dc.contributor.author | Costantino, IM | en_US |
dc.contributor.author | McCabe, GP | en_US |
dc.contributor.author | Frosch, MP | en_US |
dc.contributor.author | George, JM | en_US |
dc.contributor.author | Bezard, E | en_US |
dc.contributor.author | Rochet, J-C | en_US |
dc.date.accessioned | 2017-05-19T10:29:18Z | |
dc.date.available | 2016-12-10 | en_US |
dc.date.issued | 2017-01-10 | en_US |
dc.date.submitted | 2017-05-16T13:37:42.401Z | |
dc.identifier.issn | 2051-5960 | en_US |
dc.identifier.other | ARTN 3 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23186 | |
dc.description.sponsorship | This work was supported by a grant from the Branfman Family Foundation (J.-C. R.), a Richard F. Borch Research Enhancement Award (J.-C. R.), a Purdue Research Foundation Fellowship (J.-C. R. and D. Y.), a McKeehan Fellowship and a Bilsland Dissertation Fellowship provided by the College of Pharmacy at Purdue University (D. Y.), a Floss Endowment Research Award provided by the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University (D.Y), grants from l’Agence Nationale de la Recherche (ANR-12-BSV4-001-01-TargetPD, to E.B.) and LabEx BRAIN (E.B. and B.D.), and NIH grant P50 AG005134 (M.P.F.). | en_US |
dc.relation.ispartof | ACTA NEUROPATHOLOGICA COMMUNICATIONS | en_US |
dc.rights | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | |
dc.subject | alpha-Synuclein | en_US |
dc.subject | Endosulfine-alpha | en_US |
dc.subject | Neurodegeneration | en_US |
dc.subject | Parkinson's disease | en_US |
dc.subject | Synucleinopathy | en_US |
dc.title | Endosulfine-alpha inhibits membrane-induced alpha-synuclein aggregation and protects against alpha-synuclein neurotoxicity | en_US |
dc.type | Article | |
dc.rights.holder | © The Author(s). 2017 | |
dc.identifier.doi | 10.1186/s40478-016-0403-7 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000391511600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 5 | en_US |